Stoke Therapeutics, Inc.
STOK
$9.66
$0.303.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 60.34% | -2.86% | 2.57% | 2.17% | -9.84% |
| Total Depreciation and Amortization | -2.59% | -1.46% | -2.66% | -9.78% | -2.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.70% | -2.36% | 29.72% | -9.51% | -6.21% |
| Change in Net Operating Assets | -522.14% | -10,710.00% | 99.36% | -436.11% | -149.29% |
| Cash from Operations | -7.30% | -23.68% | 28.86% | -18.97% | -19.62% |
| Capital Expenditure | 59.22% | -123.91% | -283.33% | 94.76% | 40.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.88% | 66.11% | -982.32% | -33.33% | 0.00% |
| Cash from Investing | 102.73% | 66.01% | -983.84% | -32.38% | 1.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.04% | -93.24% | 6,926.79% | -76.62% | 1,206.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.04% | -93.24% | 6,926.79% | -76.62% | 1,206.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.83% | -391.78% | 215.82% | -977.88% | 170.33% |